HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

2- (4- chlorophenyl)- 2,5- dihydropyrazolo(4,3- c)quinoline- 3(3H)- one

inhibits binding of benzodiazepine cpds to benzodiazepine receptors in the brain
Also Known As:
CGS 9896; CGS-9896; 3H-Pyrazolo(4,3-c)quinolin-3-one, 2-(4-chlorophenyl)-2,5-dihydro-
Networked: 14 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Mosbacher, Johannes: 1 article (03/2011)
2. Nozulak, Joachim: 1 article (03/2011)
3. Hurth, Konstanze: 1 article (03/2011)
4. Kaupmann, Klemens: 1 article (03/2011)
5. Tintelnot-Blomley, Marina: 1 article (03/2011)
6. Aichholz, Reiner: 1 article (03/2011)
7. Hintermann, Samuel: 1 article (03/2011)
8. Blanz, Joachim: 1 article (03/2011)

Related Diseases

1. Seizures (Seizure)
2. Hyperphagia
3. Ataxia (Dyssynergia)
4. Ulcer
5. Stomach Ulcer (Gastric Ulcer)

Related Drugs and Biologics

1. Pentylenetetrazole (Metrazol)
2. Diazepam (Valium)
3. GABA-A Receptors (GABA(A) Receptor)
4. Benzodiazepines
5. 2,5- dihydro- 2- (4- methoxyphenyl)- 3H- pyrazolo(4,3- c)quinolin- 3- one
6. ZK 91296
7. methyl 6,7- dimethoxy- 4- ethyl- beta- carboline- 3- carboxylate
8. 2- phenylpyrazolo(4,3- c)quinolin- 3(5H)- one
9. Oxygen
10. Ligands

Related Therapies and Procedures

1. Traction